| Not Yet Recruiting | Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valen Cervical Cancer Prevention | N/A | 2026-04-12 |
| Active Not Recruiting | Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine Influenza | Phase 4 | 2025-10-12 |
| Completed | The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Liv Influenza | Phase 4 | 2024-09-21 |
| Recruiting | Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants Pertussis, Diphtheria, Tetanus | N/A | 2024-09-05 |
| Completed | Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine Streptococcus Pneumoniae Pneumonia | Phase 2 | 2024-04-20 |
| Completed | PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine Streptococcus Pneumoniae Pneumonia | EARLY_Phase 1 | 2023-11-18 |
| Unknown | Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults COVID-19 | Phase 4 | 2023-05-18 |
| Completed | Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine COVID-19 | Phase 4 | 2022-04-23 |
| Completed | Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-C COVID-19 | Phase 3 | 2022-01-22 |
| Unknown | Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients COVID-19, Pulmonary Tuberculosis | Phase 4 | 2021-12-22 |
| Completed | A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months Influenza | Phase 1 | 2021-10-26 |
| Unknown | A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years Influenza | Phase 4 | 2021-09-19 |
| Completed | A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years Influenza | Phase 4 | 2021-09-11 |
| Completed | Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) COVID-19 | Phase 4 | 2021-08-26 |
| Completed | Heterologous Prime-boost Immunization with an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5 COVID-19 | Phase 1 / Phase 2 | 2021-08-14 |
| Completed | Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vec COVID-19 | Phase 4 | 2021-05-25 |
| Completed | Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit V COVID-19 | Phase 4 | 2021-04-07 |
| Unknown | Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells) COVID-19 | Phase 2 | 2021-03-23 |
| Completed | Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults COVID-19 | Phase 4 | 2021-03-08 |
| Withdrawn | Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells) COVID-19 | Phase 2 | 2021-02-01 |
| Completed | A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) COVID-19 | Phase 2 | 2020-11-17 |
| Unknown | Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) COVID-19 | Phase 1 | 2020-10-30 |
| Completed | The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine Adenovirus Type-5 Vectored COVID-19 Vaccine | Phase 1 | 2020-09-26 |
| Completed | Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) COVID-19 | Phase 1 | 2020-08-28 |
| Unknown | Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens Plague | Phase 2 | 2020-05-08 |
| Completed | A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults Staphylococcus Aureus Infection | Phase 1 | 2019-05-16 |
| Completed | Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71 Hand, Foot and Mouth Disease | Phase 4 | 2019-05-01 |
| Completed | Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in Ch Hand, Foot and Mouth Disease | Phase 4 | 2019-04-01 |
| Completed | Immunity Duration of Rabies Vaccine and Booster Dose Effects at 10 Years Post-primary Vaccination Rabies | N/A | 2018-08-01 |
| Unknown | Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine Hand, Foot and Mouth Disease | Phase 4 | 2018-05-24 |
| Completed | Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine. Polio and Post-Polio Syndrome | Phase 2 | 2017-12-28 |
| Completed | Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) Polio | Phase 1 / Phase 2 | 2017-11-24 |
| Completed | Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age Herpes Zoster | Phase 3 | 2017-10-06 |
| Completed | Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine . Adverse Effect and Immunogenicity of Vaccine | Phase 3 | 2017-09-10 |
| Completed | Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine Polio | Phase 1 | 2017-08-21 |
| Completed | A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults Staphylococcus Aureus Infection | Phase 1 | 2016-09-01 |
| Completed | A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Pneumonia | Phase 3 | 2016-06-01 |
| Completed | A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults Staphylococcus Aureus Infection | EARLY_Phase 1 | 2016-06-01 |
| Completed | Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chi Vaccine | Phase 3 | 2016-05-12 |
| Completed | A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years a Influenza | Phase 3 | 2016-01-01 |
| Completed | Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine Parotid Gland Infection, Fever | — | 2015-10-01 |
| Completed | A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine Ebola Disease | Phase 2 | 2015-10-01 |
| Completed | A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults Hepatitis E | Phase 1 | 2015-07-01 |
| Completed | A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization Ebola Virus Disease | Phase 1 | 2015-07-01 |
| Completed | A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in Ch Influenza | Phase 1 | 2015-05-01 |
| Completed | Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules) Safety of the Oral O1 / O139 Cholera Vaccine (Enteric Capsules) | Phase 1 | 2015-03-30 |
| Completed | A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. Ebola Virus Disease | Phase 1 | 2014-12-01 |
| Completed | Immunogenicity and Safety of Subunit Plague Vaccine Plague | Phase 2 | 2014-10-01 |
| Completed | A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants Encephalitis | Phase 3 | 2014-10-01 |
| Completed | The Study of KAP on Drink Driving in Jiangsu Province in China Drink Driving | — | 2014-03-01 |
| Completed | Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants Pertussis | Phase 3 | 2013-12-01 |
| Completed | Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Pneumococcal Infection, Influenza | Phase 4 | 2013-11-01 |
| Completed | A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine Haemophilus Influenza | Phase 3 | 2013-09-01 |
| Completed | A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children EV71-associated Disease | Phase 2 | 2012-11-01 |
| Withdrawn | A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults Healthy | Phase 1 | 2012-08-01 |
| Completed | Systems Biology of Vaccination for EV71 Vaccine in Humans Systems Biology, Early Gene, EV71 Vaccine | Phase 2 | 2012-08-01 |
| Completed | A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects Rabies | Phase 3 | 2012-08-01 |
| Completed | Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine Meningitis, Influenza | Phase 3 | 2012-04-01 |
| Completed | A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chine Hand, Foot and Mouth Disease, Herpangina, Other EV71-associated Diseases | Phase 3 | 2012-01-01 |
| Completed | Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines Hepatitis A | Phase 4 | 2011-11-01 |
| Completed | Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People Healthy | Phase 3 | 2011-10-01 |
| Completed | Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conju Group A, C Polysaccharide Meningitis, Type b Haemophilus Influenza | Phase 3 | 2011-09-01 |
| Completed | Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Chi Healthy | Phase 1 | 2011-08-01 |
| Completed | A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants Immunogenicity, Safety | Phase 2 | 2011-07-01 |
| Completed | A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants Hand, Foot, and Mouth Disease, Enterovirus Infections | Phase 1 | 2011-03-01 |
| Completed | A Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children Hand, Foot and Mouth Disease | Phase 1 | 2011-01-01 |
| Completed | Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Childre Hand, Foot and Mouth Disease, Anti-EV71, Anti-CVA16 | — | 2010-10-01 |
| Completed | Safety of H1N1 Influenza Vaccination in Pregnant Women Virus Diseases, Respiratory Tract Infections, Influenza | Phase 4 | 2009-10-01 |
| Completed | Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older Virus Diseases, Respiratory Tract Diseases, Respiratory Tract Infections | Phase 2 | 2009-07-01 |
| Completed | Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine Hepatitis B | Phase 3 | 2008-11-01 |
| Completed | The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates Virus Disease, DNA Virus Infections, Hepadnaviridae Infections | Phase 3 | 2007-04-01 |
| Completed | The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond Hepatitis b | Phase 2 / Phase 3 | 2006-11-01 |
| Completed | A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children H. Pylori Infection | Phase 3 | 2004-12-01 |